Search all trials

Find therapies in clinical trials near you – page 7

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Study on the Safety and Immune Response of the MVA-BN Vaccine Booster for Monkeypox Prevention in Previously Vaccinated Patients

Recruiting

Registered drugNo placebo

Study on the Safety and Immune Response of the MVA-BN Vaccine Booster for Monkeypox Prevention in Previously Vaccinated Patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Modified Vaccinia Ankara – Bavarian Nordic Live Virus

Contact Research Centre

Haematological malignancy+1

Recruiting

InvestigationalNo placebo

Study on Fecal Microbiota Transplantation to Prevent Complications in Patients After Stem Cell Transplant for Blood Cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Allogeneic Faecal Microbiota

Contact Research Centre

Colorectal cancer

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Volrustomig with FOLFIRI and Bevacizumab for Colorectal Cancer Patients Without Liver Metastases

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

COVID-19

Recruiting

Registered drugNo placebo

Study comparing intranasal COVID-19 vaccine (LVT-001) with mRNA vaccine (bretovameran) as booster doses in healthy adults

Registered drugNo placebo

France

Participants:18–64 years · Healthy volunteers
Substances:LVT-001

Contact Research Centre

Adenocarcinoma pancreas

Recruiting

Registered drug

Study on Optimizing NALIRIFOX and 5-FU for Metastatic Pancreatic Cancer in First-Line Treatment and Exploring Ciprofloxacin in Second-Line Therapy

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Ciprofloxacin

Contact Research Centre

Blastic plasmacytoid dendritic cell neoplasia

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Tagraxofusp and Venetoclax for Adults with Untreated Blastic Plasmacytoid Dendritic Cell Neoplasm

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:TAGRAXOFUSP

Contact Research Centre

Colitis ulcerative+1

Recruiting

InvestigationalNo placebo

Study on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drug

Study on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Diabetic neuropathy

Recruiting

Registered drug

Study on the Effectiveness and Safety of VX-993 and Pregabalin for Pain Relief in Patients with Diabetic Peripheral Neuropathy

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Pregabalin

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Prostate cancer metastatic

Recruiting

Registered drugNo placebo

Study on Re-treatment with Lutetium (177Lu) Vipivotide Tetraxetan for Men with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Gozetotide

Contact Research Centre

Find therapies in clinical trials near you – page 7

349 trials match your criteria

Study on the Safety and Immune Response of the MVA-BN Vaccine Booster for Monkeypox Prevention in Previously Vaccinated Patients

Study on the Safety and Immune Response of the MVA-BN Vaccine Booster for Monkeypox Prevention in Previously Vaccinated Patients

Haematological malignancy+1

Study on Fecal Microbiota Transplantation to Prevent Complications in Patients After Stem Cell Transplant for Blood Cancer

Colorectal cancer

Study on the Safety and Effectiveness of Volrustomig with FOLFIRI and Bevacizumab for Colorectal Cancer Patients Without Liver Metastases

COVID-19

Study comparing intranasal COVID-19 vaccine (LVT-001) with mRNA vaccine (bretovameran) as booster doses in healthy adults

Adenocarcinoma pancreas

Study on Optimizing NALIRIFOX and 5-FU for Metastatic Pancreatic Cancer in First-Line Treatment and Exploring Ciprofloxacin in Second-Line Therapy

Blastic plasmacytoid dendritic cell neoplasia

Study on the Effectiveness and Safety of Tagraxofusp and Venetoclax for Adults with Untreated Blastic Plasmacytoid Dendritic Cell Neoplasm

Colitis ulcerative+1

Study on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease

Plasma cell myeloma

Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

Acute myeloid leukaemia

Study on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Diabetic neuropathy

Study on the Effectiveness and Safety of VX-993 and Pregabalin for Pain Relief in Patients with Diabetic Peripheral Neuropathy

Triple negative breast cancer

Study on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment

Prostate cancer metastatic

Study on Re-treatment with Lutetium (177Lu) Vipivotide Tetraxetan for Men with Metastatic Castration-Resistant Prostate Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.